Ivan Gergel
Chairman @ Neuraptive Therapeutics
Ivan Gergel is a Series B investor at Neuraptive Therapeutics. Ivan Gergel is the Executive Chairman of the Board at Neuraptive Therapeutics.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Stages Ivan Gergel invests in
Countries Ivan Gergel invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Corsair Pharma
|
Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients. | $23M / Series B / Sep 20, 2023 |
Co-Investors
About Neuraptive Therapeutics
Neuraptive was founded to commercialize innovative technology from the University of Texas. The company is dedicated to bringing this technology to patients. It develops novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries. Its franchise therapeutics product is designedfor administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves.Founded in 2016, Neuraptive Therapeutics is headquartered in Lafayette, Colorado.
Neuraptive Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Carter Freeman
CFO
|
|||
David Jackson
Founding Board Member
|
|||
|
Ivan Gergel
Chairman
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
FAQ
When did Ivan Gergel last invest?
The most recent investment recorded for Ivan Gergel closed in Sep 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
